National Drug Strategy
National Drug Strategy

Comorbidity of mental disorders and substance use: a brief guide for the primary care clinician

10. Somatoform disorders and substance use

prev pageTOC |next page

Table of contents

10.1 Somatoform disorders
10.2 Comorbidity with somatoform disorders
10.3 Major clinical issues with somatoform disorders and cannabis/hallucinogen use
10.4 Major clinical issues with somatoform disorders and alcohol use
10.5 Major clinical issues with somatoform disorders and opioid use
10.6 Major clinical issues with somatoform disorders and stimulant (including methamphetamine) use
10.7 Major clinical issues with somatoform disorders and benzodiazepine use
10.8 Major clinical issues with somatoform disorders and inhalant/solvent use

prev pageTOC |next page